Building the Drug Discovery Engine of the Future with AI-Empowered Nodal Biology
Daedalus · 10.06.2026 · 155 (1-2) · 110-121
DOI: 10.1162/daed.a.976 ↗Kurz gefasst
Fachartikel in der Zeitschrift Daedalus, online erschienen am 10.06.2026. Verfasst von Anna Greka. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Inspired by the visionary predictions of Jules Verne, this essay proposes that integrating artificial intelligence with a paradigm called “nodal biology ” will revolutionize the discovery of treatments and cures. Current drug development is slow, costly, and failure-prone, constrained by the challenge of drug target identification. Solving the “cell perturbation prediction problem”-predicting how human cells respond to any disease-causing perturbation-is key to accelerating successful drug target identification. Nodal biology, the discovery of shared druggable mechanisms (nodes) among seemingly disparate diseases, offers a scalable approach to generate the high-quality data needed to train cell prediction AI models. As an example, a cargo receptor node was identified, linking dozens of genetic diseases and leading to a new drug candidate. The synergistic combination of human scientific intuition and AI-empowered nodal biology is essential for building the biomedical innovation engine of the future, ultimately accelerating treatments for all human diseases.
Zitieren
APA
Greka, A. (2026). Building the Drug Discovery Engine of the Future with AI-Empowered Nodal Biology. Daedalus, 155(1-2), 110-121. https://doi.org/10.1162/daed.a.976
Vancouver
Greka A. Building the Drug Discovery Engine of the Future with AI-Empowered Nodal Biology. Daedalus. 2026;155(1-2):110-121. doi:10.1162/daed.a.976
BibTeX
@article{Greka2026,
author = {Greka, Anna},
title = {Building the Drug Discovery Engine of the Future with AI-Empowered Nodal Biology},
journal = {Daedalus},
year = {2026},
volume = {155},
number = {1-2},
pages = {110--121},
doi = {10.1162/daed.a.976}
}
EUVIMED